Skip to main content

Bayer AG

corporate_fare Company Profile

Bayer AG

BAYRY·OTC·Life Sciences·CIK 0001144145

A Missouri circuit judge approved Bayer's $7.25B settlement of Roundup cancer claims, calling it fair, reasonable and adequate. The deal, first announced in February, resolves nearly all current and future U.S. Roundup claims and pays individuals $10K to $165K based on cancer severity, age, and whether exposure was occupational or residential. This is the legal overhang that has dogged Bayer since the 2018 Monsanto acquisition, when shares fell 80% in the years that followed. The company already won its Supreme Court case on the government-approved warning label, which undercut a central claim in many suits, so court approval removes the last major procedural hurdle. BAYZF is the same Bayer AG security on a different OTC line. Watch for the pace of remaining opt-outs and any appeals, which would determine whether the $7.25B cap actually holds.

Bayer AG (OTC:BAYRY) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 2 items for BAYRY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 8/10. Across its 2 most recent items scored 7 or higher, the top rating is 8/10, with 2 rated 8 or above.

Recent high-impact activity:

  • Judge Approves $7.25B Roundup Settlement, Clearing Bayer's Biggest Legal Overhang
  • Bayer Wins Approval for Asundexian, a First-in-Class Stroke-Prevention Drug

Short Interest & Short Volume

1.00 days to cover

FINRA reported short interest of 112,756 shares in BAYRY as of the October 30, 2026 settlement, a 64.1% decrease from the prior period — about 1.0 days to cover at its recent average daily volume. On November 20, 2026, 46.8% of BAYRY volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)112,756 shares as of October 30, 2026
Change vs prior period▼ 64.1%
Days to cover1.00 at avg daily volume of 907,649
Daily short volume (FINRA facilities)46.8% of 1,467,610 shares on November 20, 2026
5-day average short volume53.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Insider Transactions

BAYRY files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

No longer listed

BAYRY (Bayer AG) is no longer listed on a major US exchange, so Wiseek no longer shows market data for this symbol. It last appeared on NYSE. The filings and coverage below remain available as an archive.

feed BAYRY - Latest Insights

BAYRY
Nov 20, 2026, 4:51 PM EST
Source: Seeking Alpha
Importance Score:
8
BAYRY
Nov 09, 2026, 9:08 PM EST
Source: Seeking Alpha
Importance Score:
8
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets